interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Aprocitentan

Generic competition · all medicines · read 12 November 2026

Is there a generic of Aprocitentan, and who makes it?

Aprocitentan appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Aprocitentan1 dosage-form group in the Orange Book
0generic makers listed
  1. Aprocitentan appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Tryvio. No generic is listed as marketed.

2020202520302035204001brand 2024data datePatent 8324232 listed to expire 21 September 2029Patent 11174247 listed to expire 6 November 2037Patent 12297189 listed to expire 26 February 2038Patent 10919881 listed to expire 26 February 2038Patent 11787782 listed to expire 2 March 2038Patent 11680058 listed to expire 26 July 2038Exclusivity NCE to 22 March 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 22 March 2029Exclusivity NCE Tryvio
  • 21 September 2029Patent 8324232 drug substance
  • 6 November 2037Patent 11174247
  • 26 February 2038Patent 12297189 drug product
  • 26 February 2038Patent 10919881 drug substance
  • 2 March 2038Patent 11787782
  • 26 July 2038Patent 11680058

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.